InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: kei post# 3060

Monday, 05/22/2017 4:32:08 PM

Monday, May 22, 2017 4:32:08 PM

Post# of 7536
TNXP 8k: Tonix Pharmaceuticals Presented Analyses of Potential Moderators of Treatment Response to U.S. FDA-Designated Breakthrough Therapy for PTSD, TNX-102 SL, in Phase 2 AtEase Study in Military-Related PTSD http://www.tonixpharma.com/news-events/press-releases/detail/1069/tonix-pharmaceuticals-presented-analyses-of-potential

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.